Skip to content

Advertisement

Infectious Agents and Cancer

What do you think about BMC? Take part in

Editors' Profile

New Content Item

Dr Franco M Buonaguro, Co-Editor-in-Chief

Dr. Franco M. Buonaguro obtained his Medical Doctor degree at the University of Naples, Italy, in 1977, where he also became Specialist in Endocrinology in 1982, Microbiology and Virology in 1992. After a postdoctoral fellowship at the Department of Cell Biology, Argonne National Laboratory, Argonne, IL, USA (1979-81), a WHO Fellowship and research associate position at the Tumor Biology Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA (1983-86), he became an assistant member of the Experimental Oncology F – Viral Oncology at Natl Cancer Institute in Naples. He was promoted associate member in 1991, and became full member in 2001. Since 2008 Dr F.M. Buonaguro is Director of the Molecular Biology and Viral Oncogenesis Unit of the Experimental Oncology Department at the Natl Cancer Institute “Fond Pascale “ Napoli-Italy.

If you would like to contact Dr Buonaguro directly regarding a submission to the journal, please contact him on: fmbuonaguro@tim.it



New Content Item

Dr Sam M Mbulaiteye, Co-Editor-in-Chief

As a senior investigator in the Infections and Immunoepidemiology Branch (IIB), Dr. Mbulaiteye focuses his research on unraveling the role of infections, immunity, and genetic factors in the etiology of Burkitt lymphoma and Kaposi sarcoma. Both of these malignancies are endemic in Africa and their risk is substantially increased in the setting of HIV/AIDS.

Dr. Mbulaiteye received his primary medical degree from Makerere University, Kampala (1990). He earned advanced degrees in epidemiology and biostatistics (M.Phil.) from the University of Cambridge, U.K. (1994), and received specialization in internal medicine (M.Med.) from Makerere University (1996). He began his research career at the Uganda Cancer Institute (1994-1997) by leading the fieldwork on a large case-control study to measure the impact of HIV on cancer in children and adults. He transitioned to the Uganda Virus Research Institute where he tracked the population dynamics of HIV by measuring incidence and prevalence of HIV in a large rural general population in southwest Uganda in a study funded by the U.K. Medical Research Council. Dr. Mbulaiteye joined IIB as a research fellow in December 2000, and was awarded scientific tenure by the NIH and appointed senior investigator in 2013.

Please visit the following website to read further information on Dr Mbulaiteye's career and research interests:

https://dceg.cancer.gov/about/staff-directory/biographies/O-Z/mbulaiteye-sam

If you would like to contact Dr Mbulaiteye directly regarding a submission to the journal, please contact him on: mbulaits@mail.nih.gov.

2016 Journal Metrics

Advertisement